Caren van Roekel

77 Radioembolization 65. Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C, et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachy therapy: a consensus panel report from the radioembolization brachy therapy oncology consortium. Int J Rad Oncol Biol Phys. 2007;68(1):13-23. Epub 2007/04/24. 66. Borggreve AS, Landman AJ, Vissers CM, De Jong CD, Lam MG, Monninkhof EM, et al. Radioembolization: Is Prophylactic Embolization of Hepaticoenteric Arteries Necessary? A Systematic Review. Cardiovasc Interv Radiol. 2016;39(5):696- 704. Epub 2016/03/05. 67. Boas FE, Ziv E, Yarmohammadi H, Brown KT, Erinjeri JP, Sofocleous CT, et al. Adjuvant Medications That Improve Survival after Locoregional Therapy. J Vasc Interv Radiol. 2017;28(7):971-7 e4. Epub 2017/05/22. 68. Yarmohammadi H, Erinjeri JP, Brown K T. Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone. J Vasc Inter v Radiol. 2015;26(4):533-7. Epub 2015/03/26. 69. BTG. TheraSphere Yttrium-90 Glass Microspheres Instructions for Use. [15- 09-2017]; Available from: https://www. btg-im.com/BTG/media/TheraSphere- Document s/PDF/10093509 -Rev8 _ English-searchable.pdf. 70. Ahmadzadehfar H, Meyer C, Pieper CC, Bundschuh R, Muckle M, Gartner F, et al. Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration. EJNMMI research. 2015;5(1):54. Epub 2015/10/16. 71. Paprottka KJ, Lehner S, Fendler WP, Ilhan H, Rominger A, Sommer W, et al. Reduced Periprocedural Analgesia After Replacement of Water for Injection with Glucose 5% Solution as the Infusion Medium for 90Y-Resin Microspheres. J Nucl Med. 2016;57(11):1679-84. Epub 2016/11/03. 72. Customer Kit and Delivery Set. QuiremSpheres; 2017 [09 -15 - 2017]; Available from: http://www. quiremspheres.com/customer-kit.html. 73. Services UDoHaH. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. . National Cancer Institute. 2010. 74. Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Radioembolization-induced liver disease: a systematic review. Eur J Gastroent Hepatol. 2017;29(2):144-52. Epub 2016/12/08. 75. Mahnken AH. Current status of transar terial radioembolization. World J Radiol. 2016;8(5):449-59. Epub 2016/06/02. 2